Cited by 606Muscle Physiology and DisordersMuscle metabolism and nutritionMetabolism, Diabetes, and Cancer

IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1

Sacheck, Jennifer M., Ohtsuka, Akira, McLary, S. Christine, Goldberg, Alfred L.·2004·American Journal of Physiology-Endocrinology and Metabolism

Abstract

Muscle atrophy results primarily from accelerated protein degradation and is associated with increased expression of two muscle-specific ubiquitin ligases (E3s): atrogin-1 and muscle ring finger 1 (MuRF1). Glucocorticoids are essential for many types of muscle atrophy, and their effects are opposite to those of insulin-like growth factor I (IGF-I) and insulin, which promote growth. In myotubes, dexamethasone (Dex) inhibited growth and enhanced breakdown of long-lived cell proteins, especially myofibrillar proteins (as measured by 3-methylhistidine release), while also increasing atrogin-1 and MuRF1 mRNA. Conversely, IGF-I suppressed protein degradation and prevented the Dex-induced increase in proteolysis. IGF-I rapidly reduced atrogin-1 expression within 1 h by blocking mRNA synthesis without affecting mRNA degradation, whereas IGF-I decreased MuRF1 mRNA slowly. IGF-I and insulin also blocked Dex induction of these E3s and several other atrophy-related genes (“atrogenes”). Changes in overall proteolysis with Dex and IGF-I correlated tightly with changes in atrogin-1 mRNA content, but not with changes in MuRF1 mRNA. IGF-I activates the phosphatidylinositol 3-kinase (PI3K)-Akt pathway, and inhibition of this pathway [but not the calcineurin-nuclear factor of activated T cell (NFAT) or the MEK-ERK pathway] increased proteolysis and atrogin-1 mRNA expression. Thus an important component of growth stimulation by IGF-I, through the PI3K-Akt pathway, is its ability to rapidly suppress transcription of the atrophy-related E3 atrogin-1 and other atrogenes and degradation of myofibrillar proteins.

Integrity signals

Registry

Crossref · 10.1152/ajpendo.00073.2004

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Sacheck, J. M., Ohtsuka, A., McLary, S. C., & Goldberg, A. L.
Affiliations
Harvard University (US)
Venue
American Journal of Physiology-Endocrinology and Metabolism
Published
2004-10
Volume
287
Issue
4
Pages
E591-E601
ISSN
  • 0193-1849 (ISSN-L)
  • 1522-1555
OpenAlex
W2134479830
Cited by
606
References
57
Citations by year
2026: 11 · 2025: 13 · 2024: 13 · 2023: 15 · 2022: 27 · 2021: 21 · 2020: 23 · 2019: 19 · 2018: 26 · 2017: 26 · 2016: 28 · 2015: 22 · 2014: 27 · 2013: 31 · 2012: 49
FWCI
13.05
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Physiology-Endocrinology and Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Muscular Dystrophy Association
  • National Space Biomedical Research Institute
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Muscle metabolism and nutrition
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Keywords
insulin-like growth factor I, muscle atrophy, protein degradation, atrogin-1, MuRF1, ubiquitin ligase, glucocorticoids, dexamethasone, myofibrillar protein degradation, PI3K/Akt signaling, insulin, atrogenes, gene transcription, myotubes
MeSH terms
Tripartite Motif Proteins, Phosphoinositide-3 Kinase Inhibitors, Cells, Cultured, Dexamethasone, Enzyme Inhibitors, Humans, Hypoglycemic Agents, Insulin, Insulin Resistance, Insulin-Like Growth Factor I, Methylhistidines, Muscle Proteins, Muscular Atrophy, Myofibrils, RNA, Messenger, Stimulation, Chemical, Blotting, Northern, Gene Expression Regulation, Enzymologic, Muscle, Skeletal, Muscle Fibers, Skeletal, Reverse Transcriptase Polymerase Chain Reaction, Ubiquitin, Myoblasts, Ubiquitin-Protein Ligases, SKP Cullin F-Box Protein Ligases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review